Abstract
Background: Targeted temperature management (TTM) is recommended following cardiac arrest; however, time to target temperature varies in clinical practice. We hypothesised the effects of a target temperature of 33 °C when compared to normothermia would differ based on average time to hypothermia and those patients achieving hypothermia fastest would have more favorable outcomes. Methods: In this post-hoc analysis of the TTM-2 trial, patients after out of hospital cardiac arrest were randomized to targeted hypothermia (33 °C), followed by controlled re-warming, or normothermia with early treatment of fever (body temperature, ≥ 37.8 °C). The average temperature at 4 h (240 min) after return of spontaneous circulation (ROSC) was calculated for participating sites. Primary outcome was death from any cause at 6 months. Secondary outcome was poor functional outcome at 6 months (score of 4–6 on modified Rankin scale). Results: A total of 1592 participants were evaluated for the primary outcome. We found no evidence of heterogeneity of intervention effect based on the average time to target temperature on mortality (p = 0.17). Of patients allocated to hypothermia at the fastest sites, 71 of 145 (49%) had died compared to 68 of 148 (46%) of the normothermia group (relative risk with hypothermia, 1.07; 95% confidence interval 0.84–1.36). Poor functional outcome was reported in 74/144 (51%) patients in the hypothermia group, and 75/147 (51%) patients in the normothermia group (relative risk with hypothermia 1.01 (95% CI 0.80–1.26). Conclusions: Using a hospital’s average time to hypothermia did not significantly alter the effect of TTM of 33 °C compared to normothermia and early treatment of fever.
Original language | English |
---|---|
Article number | 356 |
Journal | Critical Care |
Volume | 26 |
Number of pages | 8 |
ISSN | 1364-8535 |
DOIs | |
Publication status | Published - Dec 2022 |
Bibliographical note
Funding Information:Dr Young reports receiving lecture fees from Bard Medical. Dr Wise receives honoraria from Gilead and Fisher & Paykel for educational lectures. Dr Keeble reports receiving lecture fees from BD, and a research grant from Zoll. Dr Cariou received fees from Bard Medical. Professor Taccone receives lecture fees from BD and ZOLL. Professor Friberg is a scientific advisor TEQCool (Lund, Sweden).
Publisher Copyright:
© 2022, The Author(s).
Keywords
- Hypothermia
- Out of hospital cardiac arrest
- Temperature management
- Time to target temperature
- Fever/therapy
- Cardiopulmonary Resuscitation
- Cold Temperature
- Humans
- Hypothermia, Induced
- Out-of-Hospital Cardiac Arrest/therapy
- Treatment Outcome